Molnupiravir received Emergency Use Authorization on Thursday evening in Israel. It is used to treat mild to moderate coronavirus in adults.
The green light is the first for an oral treatment for COVID-19 and the first for a COVID-19 drug that will be administered widely in the community.
Israel has played – and continues to play – a significant role in the fight for a cure for corona.
A partnership between six leading tech and pharma companies wants to create and adopt new AI technologies that could transform the process of drug discovery and development.
An authorization from the US Food and Drug Administration could help change clinical management of COVID-19 as the pill can be taken at home.
Though Singapore's health ministry did not immediately confirm the deal, it would be the fourth country to enter talks of purchase with Merck.
JPOST Digital Library
